An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: A case report

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Gupta, Sachin ^a   Jain, Amit ^a   Fanning, Tina V ^a   Couriel, Daniel R ^a   Jimenez, Carlos A ^a   Eapen, Georgie A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; GENTAMICIN; IMMUNOGLOBULIN; IVERMECTIN; LEVOFLOXACIN; MELPHALAN; MEROPENEM; PREDNISONE; RITUXIMAB; STEROID; TIABENDAZOLE; VALACICLOVIR; VANCOMYCIN; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; DEATH; FOLLICULAR LYMPHOMA; GENERAL CONDITION DETERIORATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LUNG HEMORRHAGE; MALE; NEMATODIASIS; RESPIRATORY FAILURE; SEPTIC SHOCK; STRONGYLOIDES STERCORALIS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FATAL OUTCOME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; IMMUNOCOMPROMISED HOST; IVERMECTIN; KLEBSIELLA INFECTIONS; LUNG DISEASES, PARASITIC; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY ALVEOLI; SEPSIS; SHOCK, SEPTIC; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; THIABENDAZOLE;

EID: 33745079917     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-87     Document Type: Article

References (9)

1. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV: Strongyloidiasis in patients at a comprehensive cancer center in the United States. Cancer 2004, 100:1531-1536.
2. Genta RM: Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989, 11:755-767.
3. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB: Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981, 3:397-407.
4. Kerlin RL, Nolan TJ, Schad GA: Strongyloides stercoralis: histopathology of uncomplicated and hyperinfective strongyloidiasis in the Mongolian gerbil, a rodent model for human strongyloidiasis [corrected]. Int J Parasitol 1995, 25:411-420.
5. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC: Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004, 171:479-484.
6. Orlent H, Crawley C, Cwynarski K, Dina R, Apperley J: Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2003, 32:115-117.
7. Concha R, Harrington W, Rogers AI: Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005, 39:203-211.
8. Genta RM: Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988, 89:391-394.
9. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, Biligui S, Chodakewitz J, Neu D, Danis M, Gentilini M: Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994, 88:344-345.